首页> 外文期刊>The Canadian journal of hospital pharmacy. >Characterization of Venous Thromboembolism Risk in Medical Inpatients Using Different Clinical Risk Assessment Models
【24h】

Characterization of Venous Thromboembolism Risk in Medical Inpatients Using Different Clinical Risk Assessment Models

机译:不同临床风险评估模型的医疗住院患者静脉血栓栓塞风险的表征

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Symptomatic venous thromboembolism (VTE) occurs in about 1% of patients within 3 months after admission to a medical unit. Recent evidence for thromboprophylaxis in an unselected medical inpatient population has suggested only a modest net benefit. Consequently, guidelines recommend careful risk stratification to guide thromboprophylaxis. Objectives: To compare candidacy for thromboprophylaxis according to 4 risk stratification models: a regional preprinted order (PPO) set used in the study institution, the Padua Prediction Score, and the IMPROVE predictive and associative risk assessment models. Methods: A retrospective review of health records was undertaken for patients with no contraindication to pharmacologic thromboprophylaxis who were admitted to the internal medicine service of a teaching hospital between April and July 2013. Results: Of the 298 patients in the study cohort, 238 (80.0%) received pharmacologic thromboprophylaxis on admission, ordered according to the regional PPO.
机译:背景:大约1%的患者在入院后3个月内发生症状性静脉血栓栓塞(VTE)。在未经选择的住院医疗人群中进行血栓预防的最新证据表明,只有适度的净效益。因此,指南建议仔细的风险分层来指导血栓预防。目的:根据4种风险分层模型比较血栓预防的候选资格:研究机构使用的区域预打印顺序(PPO)、Padua预测评分以及改进的预测和关联风险评估模型。方法:对2013年4月至7月在一家教学医院内科住院的无药物血栓预防禁忌症患者的健康记录进行回顾性分析。结果:在研究队列中的298名患者中,238名(80.0%)患者在入院时接受了药物性血栓预防治疗,按地区PPO排序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号